Over 70% of Americans take dietary supplements, and by now, most consumers have probably noticed the disclaimer that says "This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.”
The French government's financing initiative has approved Seventure’s Health for Life Capital fund meaning investors will devote over €5 billion to innovative companies in the field of the microbiome before the end of 2022.
The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
Formulated to sustain energy, soothe and balance the digestive process, and boost a healthy immune response, SOFAR Americas has launched a new probiotic micro-shot for kids using the patented DryCap delivery system.
Lysulin, Inc. recently announced the company has landed a patent approval for their flagship product Lysulin, a first-in-class dietary supplement formulated for those with prediabetes and type 2 diabetes.
AmericanMarijuana.org recently surveyed over 1,000 consumers who give their pets Cannabidiol (CBD). The survey aimed to gauge the attitudes of pet owners, their veterinarians, and what factors influenced their decisions.